Meet-the-Expert |
Clinical Trial Update |
Science in Progress |
Simultaneous Sessions I |
Hematolgy-in-Focus Session |
Clinical Trial Update |
Simultaneous Sessions II |
Lunch Debate |
EHA / ASH Joint Symposium on Stem Cell Banking |
EHA Business Meeting |
Presidential Symposium |
Plenary Session I |
Poster Session II
LUNCH DEBATE
12.00 - 13.00 hours, Room: Mozart I
ARE MONOCLONAL ANTIBODIES CHALLENGING THE DOSEINTENSITY
CONCEPT IN YOUNG PATIENTS WITH AGGRESSIVE NHL?
Chair: M. Björkholm (Karolinska Institute, Stockholm, Sweden)
YES
H. Tilly (Centre Henri Becquerel, Rouen, France)
NO
N. Schmitz (Asklepios Klinik St. Georg, Hamburg, Germany)
LUNCH DEBATE
12.00 - 13.00 hours, Room: Mozart II
TRAVELLER’ S THROMBOSIS – DOES IT EXIST AND ARE WE READY
TO GIVE PROPHYLAXIS?
Chair: H. Büller (Academic Medical Center, Amsterdam, The Netherlands)
YES
J. Conard (Hotel-Dieu Hospital, Paris, France)
NO
F. Rosendaal (Leiden University Medical Center, Leiden, The Netherlands)
LUNCH DEBATE
12.00 - 13.00 hours, Room: Mozart III
IS THERE A ROLE FOR IMMUNOTHERAPY AS FIRST THERAPY IN
LOW-RISK MYELODYSPLASTIC SYNDROMES?
Chair: N. Zoumbos (Patras University Medical School, Patras, Greece)
YES
G. Mufti (King's College London, London, United Kingdom)
NO
E. Hellström-Lindberg (Karolinska Institutet, Stockholm, Sweden)
